On 3 March 2016, a group of
Harvard scientists reported that taking low dose aspirin every day may lower
the overall risk of cancer by 3 percent. The study was published in Jama
Oncology. The study concluded that long-term aspirin use was associated with a
modest but significantly reduced risk for overall cancer, especially
gastrointestinal tract tumours. Regular aspirin use may prevent a substantial
proportion of colorectal cancers and complement the benefits of screening.
Highlights:
· Taking aspirin
of 81mg a day for at least six years saw the risk of cancer of any kind drop by
3 percent.
·
The middle
aged people who regularly took aspirin were less likely to be diagnosed with
cancer of any kind.
·
It is
particularly effective at warding off cancers of the digestive system.
·
The most
dramatic impact was seen for bowel cancer.
No comments:
Post a Comment